CAR19 monitoring by peripheral blood immunophenotyping reveals histology-specific expansion and toxicity.

Autor: Hamilton MP; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA.; Division of Blood and Marrow Transplantation and Cellular Therapy, Department of Medicine, Stanford University School of Medicine, Stanford, CA.; Division of Oncology, Department of Medicine, Stanford University School of Medicine, Stanford, CA., Craig E; Department of Biomedical Data Science, Stanford University School of Medicine, Stanford, CA., Gentille Sanchez C; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA., Mina A; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA., Tamaresis J; Department of Biomedical Data Science, Stanford University School of Medicine, Stanford, CA., Kirmani N; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA., Ehlinger Z; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA., Syal S; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA., Good Z; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA.; Department of Biomedical Data Science, Stanford University School of Medicine, Stanford, CA., Sworder B; Division of Oncology, Department of Medicine, Stanford University School of Medicine, Stanford, CA., Schroers-Martin J; Division of Oncology, Department of Medicine, Stanford University School of Medicine, Stanford, CA., Lu Y; Department of Biomedical Data Science, Stanford University School of Medicine, Stanford, CA., Muffly L; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA.; Division of Blood and Marrow Transplantation and Cellular Therapy, Department of Medicine, Stanford University School of Medicine, Stanford, CA., Negrin RS; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA.; Division of Blood and Marrow Transplantation and Cellular Therapy, Department of Medicine, Stanford University School of Medicine, Stanford, CA., Arai S; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA.; Division of Blood and Marrow Transplantation and Cellular Therapy, Department of Medicine, Stanford University School of Medicine, Stanford, CA., Lowsky R; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA.; Division of Blood and Marrow Transplantation and Cellular Therapy, Department of Medicine, Stanford University School of Medicine, Stanford, CA., Meyer E; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA.; Division of Blood and Marrow Transplantation and Cellular Therapy, Department of Medicine, Stanford University School of Medicine, Stanford, CA., Rezvani AR; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA.; Division of Blood and Marrow Transplantation and Cellular Therapy, Department of Medicine, Stanford University School of Medicine, Stanford, CA., Shizuru J; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA.; Division of Blood and Marrow Transplantation and Cellular Therapy, Department of Medicine, Stanford University School of Medicine, Stanford, CA., Weng WK; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA.; Division of Blood and Marrow Transplantation and Cellular Therapy, Department of Medicine, Stanford University School of Medicine, Stanford, CA., Shiraz P; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA.; Division of Blood and Marrow Transplantation and Cellular Therapy, Department of Medicine, Stanford University School of Medicine, Stanford, CA., Sidana S; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA.; Division of Blood and Marrow Transplantation and Cellular Therapy, Department of Medicine, Stanford University School of Medicine, Stanford, CA., Bharadwaj S; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA.; Division of Blood and Marrow Transplantation and Cellular Therapy, Department of Medicine, Stanford University School of Medicine, Stanford, CA., Smith M; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA.; Division of Blood and Marrow Transplantation and Cellular Therapy, Department of Medicine, Stanford University School of Medicine, Stanford, CA., Dahiya S; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA.; Division of Blood and Marrow Transplantation and Cellular Therapy, Department of Medicine, Stanford University School of Medicine, Stanford, CA., Sahaf B; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA., Kurtz DM; Division of Oncology, Department of Medicine, Stanford University School of Medicine, Stanford, CA., Mackall CL; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA.; Division of Blood and Marrow Transplantation and Cellular Therapy, Department of Medicine, Stanford University School of Medicine, Stanford, CA., Tibshirani R; Department of Biomedical Data Science, Stanford University School of Medicine, Stanford, CA., Alizadeh AA; Division of Oncology, Department of Medicine, Stanford University School of Medicine, Stanford, CA.; Institute for Stem Cell Biology and Regenerative Medicine, Stanford University, Stanford, CA.; Stanford Cancer Institute, Stanford University, Stanford, CA., Frank MJ; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA.; Division of Blood and Marrow Transplantation and Cellular Therapy, Department of Medicine, Stanford University School of Medicine, Stanford, CA., Miklos DB; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA.; Division of Blood and Marrow Transplantation and Cellular Therapy, Department of Medicine, Stanford University School of Medicine, Stanford, CA.

Publikováno v: Blood advances [Blood Adv] 2024 Jun 25; Vol. 8 (12), pp. 3314-3326.

COMPARATIVE ACCURACY OF ALTERNATIVE EARLY MEASURES OF RESIDUAL DISEASE AFTER CAR19 THERAPY OF RELAPSED/REFRACTORY LBCL.

Autor: Sworder, B. J., Alig, S. K., Shukla, N., Garofalo, A., Macaulay, C. W., Esfahani, M. Shahrokh, Olsen, M. N., Hamilton, J., Hosoya, H., Hamilton, M. P., Spiegel, J. Y., Baird, J. H., Carleton, M., Younes, S. F., Schroers‐Martin, J. G., Liu, C. L., Natkunam, Y., Majzner, R. G., Mackall, C. L., Miklos, D. B.

Publikováno v: Hematological Oncology; Jun2023 Supplement S2, Vol. 41, p214-216, 3p

B-cell lymphomas present immunoglobulin neoantigens.

Autor: Khodadoust MS; Division of Oncology, Department of Medicine., Olsson N; Department of Chemical and Systems Biology., Chen B; Division of Oncology, Department of Medicine.; Department of Genetics., Sworder B; Division of Oncology, Department of Medicine., Shree T; Division of Oncology, Department of Medicine., Liu CL; Division of Oncology, Department of Medicine., Zhang L; Department of Chemical and Systems Biology., Czerwinski DK; Division of Oncology, Department of Medicine., Davis MM; Department of Microbiology and Immunology.; Howard Hughes Medical Institute., Levy R; Division of Oncology, Department of Medicine., Elias JE; Department of Chemical and Systems Biology., Alizadeh AA; Division of Oncology, Department of Medicine.; Center for Cancer Systems Biology, and.; Institute for Stem Cell Biology and Regenerative Medicine, Stanford University, Stanford, CA.

Publikováno v: Blood [Blood] 2019 Feb 21; Vol. 133 (8), pp. 878-881. Date of Electronic Publication: 2018 Dec 13.

Decoding the Dynamics of Circulating Tumor DNA in Liquid Biopsies.

Autor: Turabi, Khadija^1,2 (AUTHOR), Klute, Kelsey^2,3 (AUTHOR), Radhakrishnan, Prakash^1,2 (AUTHOR) pradhakr@unmc.edu

Publikováno v: Cancers. Jul2024, Vol. 16 Issue 13, p2432. 26p.

Starry Sky Appearance of an Amyloid Heart in Plasma Cell Dyscrasias.

Autor: Das, Debasish¹ (AUTHOR) dasdebasish54@gmail.com, Acharya, Debasis¹ (AUTHOR), Mahanta, Dibya Sundar¹ (AUTHOR), Deb, Pranjit¹ (AUTHOR)

Publikováno v: Journal of the Practice of Cardiovascular Sciences. May-Aug2024, Vol. 10 Issue 2, p108-112. 5p.